Benzinga | Oct 12, 2020 10:17AM EDT

SVB Leerink Maintains Market Perform on Abiomed, Lowers Price Target to $280

SVB Leerink maintains Abiomed (NASDAQ:ABMD) with a Market Perform and lowers the price target from $335 to $280.